TECX
Tectonic Therapeutic, Inc.
NASDAQ: TECX · HEALTHCARE · BIOTECHNOLOGY
$20.50
-0.29% today
Updated 2026-10-29
Market cap
$390.01M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.57
Dividend yield
—
52W range
$16 – $40
Volume
0.2M
WallStSmart proprietary scores
31
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C8.5
Quality
A3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
14.6
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →272 stocks currently score above 75
Price targets
Analyst target
$71.00
+246.34%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 14.55 — safe zone
+ Debt/equity 0.02x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-21.53M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-32.18M | $-42.82M | $-57.98M | $-74.15M | $-22.29M |
| EPS | — | — | — | — | $-4.57 |
| Free cash flow | $-97.47M | $-40.96M | $-59.24M | $-60.29M | $-21.53M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Tectonic Therapeutic, Inc. trades at $20.50. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 14.55, it sits in the safe zone.
Frequently asked questions
What is Tectonic Therapeutic, Inc.'s stock price?
Tectonic Therapeutic, Inc. (TECX) trades at $20.50.
Is Tectonic Therapeutic, Inc. overvalued?
Tectonic Therapeutic, Inc. carries a Smart Value Score of 31/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Tectonic Therapeutic, Inc. (TECX)?
The 12-month analyst consensus target is $71.00, about 246.3% above the current $20.50. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Tectonic Therapeutic, Inc.'s Altman Z-Score is 14.55, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-38.32%
Beta0.38
50D MA$27.26
200D MA$28.08
Shares out0.02B
Float0.01B
Short ratio—
Avg volume0.2M
Performance
1 week-8.04%
1 month-15.21%
3 months-32.65%
YTD-3.79%
1 year+7.79%
3 years—
5 years—